View of THE INFLUENCE OF DEBT-TO-EQUITY RATIO, RETURN ON EQUITY, AND COMPANY SIZE ON STOCK RETURNS IN PHARMACEUTICAL SUBSECTOR COMPANIES LISTED ON THE IDX FOR THE 2018-2023 PERIOD

Return to Article Details THE INFLUENCE OF DEBT-TO-EQUITY RATIO, RETURN ON EQUITY, AND COMPANY SIZE ON STOCK RETURNS IN PHARMACEUTICAL SUBSECTOR COMPANIES LISTED ON THE IDX FOR THE 2018-2023 PERIOD Download Download PDF